Mass causality events, civilian-based terrorism, and traumatic injury on the military battlefield have highlighted the shortcomings of traditional blood product storage and use within these challenging front line environments. Preparedness and prevention of death from hemorrhage requires the availability and placement of new and innovative blood products with first responders (civilian EMS, military medics, and rural or isolated emergency rooms). This work shop will provide an update on the status of investigational blood products which are designed to meet this front line need (and which are the most advanced in clinical development): freeze dried plasma, spray dried plasma and freeze dried platelets.
Classify next generation blood products, their indications, clinical safety and efficacy results, and their associated development timelines.
Differentiate the advantages of next generation blood products from current traditional blood products, including improved time to initiation of transfusion and inventory management.
Evaluate the inclusion of next generation blood products into modernized first responder protocols.
**This education session will not offer CME. You will be able to claim CE for the session.
Please note: Jose Cancelas Perez, MD, PhD did not consent to be recorded; therefore, the on-demand presentation and handout have been modified accordingly.